Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 21, 2014; 20(19): 5875-5880
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5875
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5875
Variable | n | P value |
Sex | ||
Male | 48 | 0.119 |
Female | 32 | |
Age (yr) | ||
≤ 60 | 37 | 0.993 |
> 60 | 43 | |
Pancreatic location (n) | ||
Head | 62 | 0.378 |
Body or tail | 18 | |
Stage | ||
I/II | 55 | < 0.001 |
III/IV | 25 | |
Pathological differentiation | ||
Well | 28 | 0.697 |
Moderate | 18 | |
Poor | 34 | |
Tumor size | ||
> 2cm | 56 | 0.339 |
≤ 2cm | 24 | |
Lymph node metastasis | ||
Yes | 34 | 0.043 |
No | 25 | |
Distant metastasis | ||
Yes | 8 | < 0.001 |
No | 72 | |
Surgical resection | ||
Yes | 59 | < 0.001 |
No | 21 | |
SUVmax | ||
High | 40 | < 0.001 |
Low | 40 | |
CA19-9 | ||
High | 40 | 0.001 |
Low | 40 | |
SUVmax plus CA19-9 | ||
Both are high | 29 | 0.002 |
Others | 51 |
- Citation: Zhao JG, Hu Y, Liao Q, Niu ZY, Zhao YP. Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer. World J Gastroenterol 2014; 20(19): 5875-5880
- URL: https://www.wjgnet.com/1007-9327/full/v20/i19/5875.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i19.5875